Viewing StudyNCT04541251



Ignite Creation Date: 2024-05-06 @ 3:11 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04541251
Status: UNKNOWN
Last Update Posted: 2021-06-23
First Post: 2020-02-09

Brief Title: Neoadjuvant Camrelizumab Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions & Keywords Data

Conditions:
Name
Lung Cancer Non-small Cell
Artificial Intelligence
Keywords:
Name View
Non-small cell lung cancer View
Neoadjuvant therapy View
Immune checkpoint inhibitor View
Major pathological response View
Artificial intelligence View